Drug
3% Sodium Chloride
3% Sodium Chloride is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
67%(2 trials)
Phase Distribution
Ph not_applicable
1
20%
Ph phase_2
1
20%
Ph early_phase_1
1
20%
Ph phase_4
1
20%
Ph phase_1
1
20%
Phase Distribution
2
Early Stage
1
Mid Stage
1
Late Stage
Phase Distribution5 total trials
Early Phase 1First-in-human
1(20.0%)
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
1(20.0%)
Phase 4Post-market surveillance
1(20.0%)
N/ANon-phased studies
1(20.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
60.0%
3 of 5 finished
Non-Completion Rate
40.0%
2 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(3)
Terminated(2)
Detailed Status
Completed3
Withdrawn2
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Early Phase 11 (20.0%)
Phase 11 (20.0%)
Phase 21 (20.0%)
Phase 41 (20.0%)
N/A1 (20.0%)
Trials by Status
completed360%
withdrawn240%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_2
Nebulised 3% Hypertonic Saline in Infants With Acute Bronchiolitis
NCT06558461
withdrawnearly_phase_1
Small-Volume, Patient-Specific, Balanced Hypertonic Fluid Protocol Validation
NCT03330704
withdrawnphase_1
Effects of 3% Sodium Chloride on Post-operative Dysphagia Following Anterior Cervical Spine Surgery
NCT03677310
completedphase_4
Nebulized 3% Hypertonic Saline Solution Treatment of Bronchiolitis in Infants
NCT02233985
completednot_applicable
A Study of Hypertonic Saline for Infants Hospitalized With Bronchiolitis
NCT01488448
Clinical Trials (5)
Showing 5 of 5 trials
NCT06558461Phase 2
Nebulised 3% Hypertonic Saline in Infants With Acute Bronchiolitis
NCT03330704Early Phase 1
Small-Volume, Patient-Specific, Balanced Hypertonic Fluid Protocol Validation
NCT03677310Phase 1
Effects of 3% Sodium Chloride on Post-operative Dysphagia Following Anterior Cervical Spine Surgery
NCT02233985Phase 4
Nebulized 3% Hypertonic Saline Solution Treatment of Bronchiolitis in Infants
NCT01488448Not Applicable
A Study of Hypertonic Saline for Infants Hospitalized With Bronchiolitis
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5